Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach-Reference-Cited by-同舟云学术

Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach

Published:2013-11-20 Issue:6 Volume:76 Page:868-879
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Bartels Christian¹,Looby Michael¹,Sechaud Romain²,Kaiser Guenther²

Affiliation:

1. Novartis Pharma AG Basel Switzerland

2. Novartis Institutes for Biomedical Research Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12118

Reference27 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD).Global strategy for the diagnosis management and prevention of COPD.2011. Updated December 2011. Available athttp://www.goldcopd.org(last accessed 5 December 2012).

2. Pharmacokinetics of inhaled drugs

3. Relationship between lung tissue and blood plasma concentrations of inhaled budesonide

4. The right treatment for the right patient: the Novartis view on COPD;Compton C;Nature,2012

5. Glycopyrrolate Causes Prolonged Bronchoprotection and Bronchodilatation in Patients With Asthma

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pharmacokinetics of Inhaled Drugs;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2023-10-01

2. Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthma;Expert Opinion on Drug Metabolism & Toxicology;2023-06-03

3. Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics;Pharmaceutical Research;2023-04-20

4. Assessment of the predictive capability of modelling and simulation to determine bioequivalence of inhaled drugs: A systematic review;DARU Journal of Pharmaceutical Sciences;2022-01-30

5. Inhaled Medicines: Past, Present, and Future;Pharmacological Reviews;2022-01